Pharma Press Releases
Karyopharm Publishes Preclinical and Phase 1 Clinical Data for Selinexor in Ovarian Cancer in Clinical Cancer Research Publication
Wednesday, September 28, 2016 GLOBE NEWSWIREXPO1 Inhibition Significantly Reduced Tumor Burden in Platinum Sensitive and Resistant Ovarian Cancer Models Company to Report Updated Phase 2 SIGN Data of Selinexor in Gynecological Malignancies at ESMO 2016 NEWTON Mass Sept 28 2016 GLOBE NEWSWIRE Karyopharm Therapeutics Inc NasdaqKPTI ..
Immune Design Announces Advancement of First GLAASbased Allergy Program into Clinical Development
Wednesday, September 28, 2016 GLOBE NEWSWIRESEATTLE and SOUTH SAN FRANCISCO Calif Sept 28 2016 GLOBE NEWSWIRE Immune Design NasdaqIMDZ a clinicalstage immunotherapy company focused on cancer today announced the application of its GLAAS discovery platform in Sanofis Phase 1 clinical trial evaluating a novel therapeutic candidate for the ..
Cascadian Therapeutics Announces Poster Presentations on Tucatinib at the European Society of Medical Oncology ESMO 2016 Congress
Wednesday, September 28, 2016 GLOBE NEWSWIRESEATTLE Sept 28 2016 GLOBE NEWSWIRE Cascadian Therapeutics NASDAQCASC a clinicalstage biopharmaceutical company today announced two upcoming poster presentations on tucatinib ONT380 the Companys lead product candidate for the treatment of HER2 breast cancer at the European Society of Medical O..
Chembio Awarded CDC Contract for Zika Dengue and Chikungunya Surveillance Testing in India Peru Guatemala and Haiti
Wednesday, September 28, 2016 GLOBE NEWSWIREMEDFORD NY Sept 28 2016 GLOBE NEWSWIRE Chembio Diagnostics Inc NasdaqCEMI a leader in pointofcare POC diagnostic tests for infectious diseases today announced that the Company has been awarded a 330000 contract by the US Centers for Disease Control and Prevention CDC for the purchase of POC su..
October 3rd Deadline in Lawsuit for Investors in shares of Keryx Biopharmaceuticals NASDAQKERX announced by Shareholders Foundation
Wednesday, September 28, 2016 GLOBE NEWSWIRESAN DIEGO Sept 28 2016 GLOBE NEWSWIRE The Shareholders Foundation Inc announces that a deadline is coming up on October 3 2016 in the lawsuit that was filed for certain investors in shares of Keryx Biopharmaceuticals NASDAQKERX over alleged Securities Laws Violations by Keryx Biopharmaceuticals ..
KLOX Technologies reports on its interim results from its ongoing clinical studies on LumiHeal for the treatment of chronic wounds and postsurgical scarring
Wednesday, September 28, 2016 GLOBE NEWSWIRELAVAL Quebec Sept 28 2016 GLOBE NEWSWIRE Today clinical interim results on KLOX Technologies Klox LumiHealTM for the treatment of hardtoheal nonresponsive chronic wounds and postsurgical scarring will be reported in conjunction with the 2016 World Union of Wound Healing Societies WUWHS Congress ..
Merck KGaA Darmstadt Germany to Present New Research Focused on HardtoTreat Cancers at ESMO 2016
Wednesday, September 28, 2016 PR NewswireDARMSTADT Germany September 28 2016 PRNewswire Not intended for UKbased media ESMO Abstract Avelumab 777PD 7775PD 1154P 842TiP 844TiP Erbitux 527P 491P 967P 994P Tepotinib 1257P 1287TiP 1292TiP Merck KGaA Darmstadt Germany to feature new research from marketed and pipeline compounds Prelim..
Merck to Present New Research Focused on HardtoTreat Cancers at ESMO 2016
Wednesday, September 28, 2016 PR NewswireDARMSTADT Germany September 28 2016 PRNewswire Not intended for UK or USbased media ESMO Abstract Avelumab 777PD 775PD 1154P 842TiP 844TiP Erbitux 527P 491P 967P 994P Tepotinib 1257P 1287TiP 1292TiP Merck to feature new research from marketed and pipeline compounds Preliminary results fr..
Array BioPharma Announces Pricing of Public Offering of Common Stock
Tuesday, September 27, 2016 PR NewswireBOULDER Colo Sept 27 2016 PRNewswire Array BioPharma Inc Nasdaq ARRY announced today the pricing of an underwritten public offering of 18400000 shares of its common stock at a public offering price of 625 per share The gross proceeds from the sale of the shares before underwriting discounts and co..
Neogen reports 12 revenue increase
Tuesday, September 27, 2016 PR NewswireLANSING Mich Sept 27 2016 PRNewswire Neogen Corporation Nasdaq NEOG announced today that revenues for the first quarter of its 2017 fiscal year which ended Aug 31 were 83645000 a 12 increase compared to revenues of 74860000 in the first quarter of last year First quarter net income increased 6..
StemoniX Wins MN Cup Grand Prize named Best Breakthrough Business Idea of 2016
Tuesday, September 27, 2016 PR NewswireMINNEAPOLIS Sept 27 2016 PRNewswire StemoniX a company developing breakthrough stem cell technologies was recognized as one of todays most innovative and market changing businesses earning the Grand Prize and title of Best Breakthrough Business Idea of 2016 at the 12th annual MN Cup awards The M..
UpsherSmith Enters into Exclusive development and Distribution Agreement with Pharmathen SA
Tuesday, September 27, 2016 PR NewswireMAPLE GROVE Minn Sept 27 2016 PRNewswire UpsherSmith Laboratories Inc UpsherSmith today announced that it has entered into an exclusive agreement with Pharmathen SA to develop and distribute a generic product in a market category with US sales of more than 500 million IMS Health 12 months ending i..
BIOMEDevice and ESC Silicon Valley Partner for December Event at the San Jose Convention Center
Tuesday, September 27, 2016 PR NewswireSAN FRANCISCO Sept 27 2016 PRNewswire BIOMEDevice San JoseandESC Silicon Valley will join forces for the first time this year to bring professionals from the medtech and engineering spaces together for their colocated events in San Jose CA Both events will offer programs specific to the latest tre..
Helix Twelve Pharmaceuticals Appoints Fred R Seddiqui as Chief Executive Officer
Tuesday, September 27, 2016 PR NewswirePALO ALTO Calif Sept 27 2016 PRNewswire Helix Twelve Pharmaceuticals Inc a privately held pharmaceutical company focused on the development of nextgeneration precision therapeutics today announced that its Board of Directors has appointed Fred R Seddiqui as Chief Executive Officer effective immedi..
VWR Selected for Philadelphia Business Journals 2016 Best Places to Work
Tuesday, September 27, 2016 PR NewswireRADNOR Pa Sept 27 2016 PRNewswire VWR NASDAQVWR the leading global independent provider of product and service solutions to laboratory and production customers was recently named one of the 2016 Best Places to Work in Greater Philadelphia by the Philadelphia Business Journal More than 250 compa..
Rich Pharmaceuticals Inc Announces Quarterly Milestones
Tuesday, September 27, 2016 PR NewswireBEVERLY HILLS Calif Sept27 2016 PRNewswire Rich Pharmaceuticals Inc OTC Markets RCHA Rich Pharmaceuticals or the Company a biopharmaceutical company focused on developing and commercializing innovative therapies in oncology announced today several of the milestones it had reached during the past ..
Advances in computational biology and artificial intelligence used to identify compounds with potential to extend human life
Tuesday, September 27, 2016 PR NewswireBALTIMORE Sept 27 2016 PRNewswire Insilico Medicine Inc and Life Extension today announced the publication of a research paper describing the applications of its human signaling pathwaycentric GeroScope platform for scoring human tissuespecific geroprotective properties of compounds implicated in ..
VirMedica to Present at CBIs 7th HUB and SPP Model Optimization Conference
Tuesday, September 27, 2016 PR NewswireBOSTON Sept 27 2016 PRNewswire VirMedica the leader in providing eaccess technology solutions designed to expedite patient access to biopharmaceutical products today announced that the Company will participate in CBIs 7th HUB and SPP Model Optimization Conference CBIs HUB Model Conference Series..
OGT Simplifies Detection of Important Cancer Gene Variants
Tuesday, September 27, 2016 PR NewswireOXFORD England September 27 2016 PRNewswire Oxford Gene Technology OGT The Molecular Genetics Company has launched its SureSeq myPanel NGS Custom Cancer Panels to provide scientists with completely customised preoptimised next generation sequencing NGS probe panels relevant to their research The..
Nexus BioPharma Inc Provides Business Outlook and Sets Corporate Milestones
Tuesday, September 27, 2016 PR NewswireMONTCLAIR NJ Sept 27 2016 PRNewswire Nexus BioPharma Inc OTCBB NEXS a company specializing in the development of a weight loss drug therapy today provided a business overview to outline the clinical status of its flagship weight loss product candidate currently in preclinical development for t..
